MARSHALL WACE, LLP - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 199 filers reported holding IMPAX LABORATORIES INC in Q3 2016. The put-call ratio across all filers is 1,411.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q2 2016$252,000
-86.0%
8,729
-84.4%
0.00%
-88.2%
Q1 2016$1,796,000
-45.2%
56,090
-26.8%
0.02%
-45.2%
Q4 2015$3,276,000
+1014.3%
76,624
+1122.1%
0.03%
+675.0%
Q1 2015$294,000
-96.0%
6,270
-97.4%
0.00%
-96.3%
Q2 2014$7,269,000242,3960.11%
Other shareholders
IMPAX LABORATORIES INC shareholders Q3 2016
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 560,400$9,022,0003.93%
NORTH TIDE CAPITAL, LLC 1,000,000$16,100,0003.58%
Sivik Global Healthcare LLC 250,000$4,025,0001.47%
MAVERICK CAPITAL LTD 7,159,336$115,265,0001.44%
SECTOR GAMMA AS 589,311$9,488,0001.38%
BRIDGER MANAGEMENT, LLC 1,341,143$21,592,0001.23%
Eos Focused Equity Management, L.P. 48,714$784,0000.89%
Bridge City Capital, LLC 47,194$760,0000.64%
Fosun International Ltd 300,000$4,830,0000.60%
Century Capital Management, LLC 203,138$3,271,0000.56%
View complete list of IMPAX LABORATORIES INC shareholders